Literature DB >> 6468432

Female pseudo-hermaphroditism due to an adrenal tumour in the mother.

J J van de Kamp, A P van Seters, A J Moolenaar, H H van Gelderen.   

Abstract

This is a report of a case of almost complete external virilisation of a girl due to an adrenocortical adenoma of the mother. The tumour, though present for many years, caused only mild symptoms in the mother; therefore detection followed only after birth of the virilised girl.

Entities:  

Mesh:

Year:  1984        PMID: 6468432     DOI: 10.1007/bf00445598

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Virilization associated with bilateral luteomas of pregnancy.

Authors:  S Polansky; E W dePapp; E B Ogden
Journal:  Obstet Gynecol       Date:  1975-05       Impact factor: 7.661

2.  Virilization of mother and fetus associated with luteoma of pregnancy: a case report with endocrinologic studies.

Authors:  B S Verkauf; E O Reiter; L Hernandez; S A Burns
Journal:  Am J Obstet Gynecol       Date:  1977-10-01       Impact factor: 8.661

Review 3.  Virilization in pregnancy coexisting with an (ovarian) mucinous cystadenoma: A case report and review of virilizing ovarian tumors in pregnancy.

Authors:  A T Verhoeven; J L Mastboom; H A van Leusden; W H van der Velden
Journal:  Obstet Gynecol Surv       Date:  1973-09       Impact factor: 2.347

4.  Male external genitalia of a girl caused by a virilizing adrenal tumour in the mother. Case report and steroid studies.

Authors:  G Mürset; M Zachmann; A Prader; J Fischer; A Labhart
Journal:  Acta Endocrinol (Copenh)       Date:  1970-12

5.  An adrenal adenoma causing virilization of mother and infant.

Authors:  P J Fuller; I G Pettigrew; J W Pike; J R Stockigt
Journal:  Clin Endocrinol (Oxf)       Date:  1983-02       Impact factor: 3.478

  5 in total
  1 in total

Review 1.  Development and function of the fetal adrenal.

Authors:  Emanuele Pignatti; Therina du Toit; Christa E Flück
Journal:  Rev Endocr Metab Disord       Date:  2022-10-18       Impact factor: 9.306

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.